Skip to main navigation
Skip to search
Skip to main content
University of Birmingham Home
Help & FAQ
Home
Research output
Profiles
Research Units
Projects
Activities
Datasets
Equipment
Prizes
Press / Media
Search by expertise, name or affiliation
CRUK/09/041:A Phase 1 Trial of Figitumumab, an IGFR-1R Antibody, in Children Aged 2-12 years Old with Relapsed/Refractory Solid Tumours
Kearns, Pamela
(Principal Investigator)
Cancer Clinical Trials Unit
Overview
Project Details
Short title
CRUK/09/041:A Phase 1 Trial of Figitumumab, an IGFR-1R Antibody, in Children Aged 2-12 years Old with Relapsed/Refractory Solid Tumours
Status
Finished
Effective start/end date
1/12/10
→
30/11/12
Funding
Cancer Research UK
View all
View less
